Conference Interview #2 of 25
Breast cancer: Mortality rates in men versus women
MDLinx
San Antonio Breast Cancer Symposium 2017
San Antonio, Texas, United States | December 05-09, 2017
Since it is unlikely for this patient population to undergo routine screening, biopsy, or mammograms, breast cancer cases are often diagnosed in the later stages in male patients. However, when adjusted for disease stage, males with breast cancer do not have higher mortality rates than their female counterparts.
Nonetheless, when the cancer is identified, treatment and management decisions cannot be determined based on evidence, since there isn’t such a large pool of male patients with breast cancer to gauge such standards of care.
“Because male breast cancer is less frequent than it is in females, there is a bit of a knowledge gap,” says Dr. Degmin.
Ultimately, “males who are found to have breast cancer should definitely be referred for genetic evaluation and considered for testing.”
From this Conference
-
5:57Exploring locoregional recurrence of breast cancerFor locoregional recurrence of breast cancer, there is no standard of care because there are so few patients in whom this occurs.
William Gradishar, MD -
3:14Managing patients with high risk breast lesionsAmy C. Degnim, MD, professor of surgery, Mayo Clinic, Rochester, MN, discusses the different management strategies for lesions that put patients at increased risk for breast...
Amy C. Degnim, MD -
1:50Tumor types, immune response, and radiotherapyOne of the most exciting areas of study currently being conducted in breast cancer is the potential of radiation therapy to convert tumors into an in situ vaccine. Silvia...
Silvia Formenti, MD -
0:52Value of chemotherapy for patients with locoregional breast cancer recurrenceIn patients with locoregional recurrence of breast cancer, the effects of chemotherapy are varied, depending on whether they have hormone receptor positive or hormone receptor...
William Gradishar, MD -
1:32The promise of radiotherapyExploring the interaction between radiation therapy and immunotherapy in enhancing responses to treatment in breast cancer patients is currently one of the main research...
Silvia Formenti, MD -
1:15The paradoxical role of family history in breast cancer riskAlthough family history can influence a patient’s risk of developing breast cancer, it does not increase that risk once other risk factors are identified.
Amy C. Degnim, MD
This activity is not sanctioned by, nor a part of, the San Antonio Breast Cancer Symposium 2017.
